Exploring the Antennae

Some 60 million light-years away in the southerly constellation Corvus, two large galaxies are colliding. Stars in the two galaxies, cataloged as NGC 4038 and NGC 4039, very rarely collide in the course of the ponderous cataclysm that lasts for hundreds of millions of years. But the galaxies’ large clouds of molecular gas and dust often do, triggering furious episodes of star formationi near the center of the cosmic wreckage. Spanning over 500 thousand light-years, this stunning view also reveals new star clusters and matter flung far from the scene of the accident by gravitational tidal forces. The remarkably sharp ground-based image includes narrowband data that highlights the characteristic red glow of atomic hydrogen gas in star-forming regions. The suggestive overall visual appearance of the extended arcing structures gives the galaxy pair its popular name – The Antennae. via NASA https://ift.tt/3w5bPJl

Wikipedia article of the day for March 27, 2021

Wikipedia article of the day is Sennacherib. Check it out: https://ift.tt/26siBH2 Summary: Sennacherib was the king of the Neo-Assyrian Empire from 705ย BC to his death in 681ย BC. He is one of the most famous Assyrian kings for his role in the Old Testament of the Bible, which describes his campaign in the Levant. The Levantine War of 701ย BC broke out after several Assyrian vassals in the region rebelled, including the Kingdom of Judah under King Hezekiah. The Assyrians invaded Judea, and Hezekiah submitted. Sennacherib faced considerable difficulty in controlling Babylonia and destroyed the city of Babylon in 689ย BC. He transferred the capital of Assyria to Nineveh, launching one of the most ambitious building projects in ancient history. He expanded the city, constructed great city walls, numerous temples and a royal garden. Sennacherib was murdered by his eldest son, who had been disinherited and hoped to seize power for himself. A younger son, Esarhaddon, raised an army, seized Nineveh, and installed himself as king as intended by Sennacherib.